학술논문

Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer.
Document Type
Article
Source
Vaccines; Jan2024, Vol. 12 Issue 1, p63, 17p
Subject
IMMUNE checkpoint inhibitors
COLORECTAL cancer
REGULATORY T cells
GRANZYMES
IPILIMUMAB
TUMOR growth
THERAPEUTICS
Language
ISSN
2076393X
Abstract
Copyright of Vaccines is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)